Skip to content

The Return of Psychedelics: A Measured Approach

Charles S. Grob

Psychiatric News April 1, 2021 DOI: 10.1176/appi.pn.2021.4.9 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Historical analysis Peer reviewed
Topics Anxiety Psilocybin
Keywords Enthusiasm Psychotherapist Mainstream Backlash Psychoanalysis Law
Key points Argues that psychedelic research, initially promising for serious refractory disorders in the 1950s and 1960s, was suppressed for decades by a cultural and political backlash and draconian laws, and that substantial rigorous study only resumed in the 21st century amid limited funding and faint mainstream interest.

Abstract

After decades of quiescence, psychedelics are back and making quite a ruckus. In the 1950s and 1960s, a flurry of cutting-edge psychedelic research engendered real enthusiasm among clinicians, suggesting potential treatment efficacy for a range of serious refractory disorders. But a cultural and political backlash led to the imposition of draconian laws, effectively sidelining psychedelic research for decades, until scientists slowly began to again explore their potential. Even then, limited funding and only faint interest from the mainstream meant that substantial and rigorous psychedelic studies did not resume until the 21st century.

Comparable studies

Other theoretical and historical papers on psilocybin for anxiety, most cited first.

Study Year Design Participants
Psychedelics as Medicines: An Emerging New Paradigm General population 2016 Theoretical or philosophical paper
Taking Psychedelics Seriously 2018 Theoretical or philosophical paper
Virtual Reality as a Moderator of Psychedelic-Assisted Psychotherapy 2022 Theoretical or philosophical paper
The Heffter Research Institute: Past and Hopeful Future 2014 Historical analysis
Out of the box: A psychedelic model to study the creative mind 2018 Theoretical or philosophical paper

Explore topics

By condition and practice